NCT02635776: Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
- State
- Completed
- Phase
- Phase 3
- People
- 555 taking part
- Started
- 22 Dec 2015
- Primary completion
- 21 Dec 2017
- Arms
- AR101 powder provided in capsules & sachets
- Results
- Posted on the registry
- 21 Dec 2015: Trial registered
- 22 Dec 2015: Trial started
- 2 Jul 2018: Trial completed
- 17 Mar 2022: Trial results posted